Digwill International Private Limited
Back to catalog
Afinitor (Everolimus) Tablets
Breast

Afinitor (Everolimus) Tablets

Afinitor Tablets is used to treat advanced (late-stage) cancers or noncancerous tumors, such as kidney and breast cancer, subependymal giant cell astrocytoma (SEGA, a brain tumor), renal angiomyolipoma (kidney tumor). Generic brands for Everolimus Tablets Available in India Brand Name Afinitor Generic Name Everolimus Strength 5mg Manufacturer Novartis India Ltd. Buy 100% authentic medicines from Aark Pharmaceuticals. Top CFA & pharma distributor supplying hospitals, clinics & patients across India. * Get the best price & exclusive discounts on Afinitor Tablets today! Call/WhatsApp Aark Pharmaceuticals at 9999156233 (Ms.Himanshi) for instant availability. Your Health Advantage: Certified Distributor, Trusted CFA Partner, Wholesale & Retail, Hospital & Clinic Supply, All Medicine Types, Life

SKU10314
Therapy areaBreast
AvailabilityAvailable on order · Bulk enquiries welcome
DistributionPan-India · Cold-chain compliant
Request quotation

About Afinitor (Everolimus) Tablets

Description Is Everolimus Tablets available in India? Yes, It is available in India. Everolimus Tablets is the salt name for the drug sold under the brand name Afinitor. It is a prescription medication primarily used as a targeted cancer therapy and as an immunosuppressant to prevent organ transplant rejection. It belongs to a class of drugs called mTOR inhibitors, which work by blocking a protein that controls cell growth and immune system activity. Cancer and Tumor Treatments – It is approved to treat various cancers (Breast Cancer, Kidney Cancer, Neuroendocrine Tumors (NET), TSC-associated Tumors and Seizures: Subependymal Giant Cell Astrocytoma (SEGA), Renal Angiomyolipoma, Partial-Onset Seizures.) Organ Transplant Prevention of Rejection – It is used with other medications (like cyclosporine or tacrolimus and corticosteroids) to prevent the body from rejecting a transplanted organ. It is approved for use in patients who have received: a kidney transplant and a liver transplant. Who is the CFA, distributor, and retailer for Afinitor (Everolimus) Tablets in India? Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Afinitor (Everolimus) Tablets in India. It is marketed by Novartis India Ltd . Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of Novartis products, including advanced cancer treatments. The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup. How much do Afinitor Tablets cost in Delhi, India? Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals Seller Name: Aark Pharmaceuticals Private Limited. Contact Person: Ms. Himanshi Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016. Mobile / WhatsApp : 9999156233 Email: sales@aarkpharma.co.in , sales@aarkpharma.com Our Branch Offices in India – New Delhi | Lucknow | Varanasi | Chandigarh | Kolkata | Patna | Jodhpur. Do you offer any discounts? Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price. Written By Mr. Sandeep Tomar (D. pharma) Last updated 12 November 2025 AM (IST)

Related products